BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17436313)

  • 1. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia.
    Salipante SJ; Benson KF; Luty J; Hadavi V; Kariminejad R; Kariminejad MH; Rezaei N; Horwitz MS
    Hum Mutat; 2007 Sep; 28(9):874-81. PubMed ID: 17436313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.
    Person RE; Li FQ; Duan Z; Benson KF; Wechsler J; Papadaki HA; Eliopoulos G; Kaufman C; Bertolone SJ; Nakamoto B; Papayannopoulou T; Grimes HL; Horwitz M
    Nat Genet; 2003 Jul; 34(3):308-12. PubMed ID: 12778173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe congenital neutropenia: genetics and pathogenesis.
    Boxer LA
    Trans Am Clin Climatol Assoc; 2006; 117():13-31; discussion 31-2. PubMed ID: 18528462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
    Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
    Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel ELANE mutations in patients with congenital neutropenia.
    Kurnikova M; Maschan M; Dinova E; Shagina I; Finogenova N; Mamedova E; Polovtseva T; Shagin D; Shcherbina A
    Pediatr Blood Cancer; 2011 Aug; 57(2):332-5. PubMed ID: 21425445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ela2 mutations and clinical manifestations in familial congenital neutropenia.
    Shiohara M; Shigemura T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Asada H; Ishii E; Koike K; Chin M; Kobayashi M; Koike K
    J Pediatr Hematol Oncol; 2009 May; 31(5):319-24. PubMed ID: 19415009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.
    Inghardt T; Antonsson T; Ericsson C; Hovdal D; Johannesson P; Johansson C; Jurva U; Kajanus J; Kull B; Michaëlsson E; Pettersen A; Sjögren T; Sörensen H; Westerlund K; Lindstedt EL
    J Med Chem; 2022 Sep; 65(17):11485-11496. PubMed ID: 36005476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of two novel mutations on the structure and function of human myeloperoxidase.
    Goedken M; McCormick S; Leidal KG; Suzuki K; Kameoka Y; Astern JM; Huang M; Cherkasov A; Nauseef WM
    J Biol Chem; 2007 Sep; 282(38):27994-8003. PubMed ID: 17650507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation.
    DeLeo FR; Goedken M; McCormick SJ; Nauseef WM
    J Clin Invest; 1998 Jun; 101(12):2900-9. PubMed ID: 9637725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase.
    Nauseef WM; Cogley M; McCormick S
    J Biol Chem; 1996 Apr; 271(16):9546-9. PubMed ID: 8621627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Characterization of known (c.607G>C) and novel (c.416C>G)
    Núñez-Núñez ME; Lona-Reyes JC; López-Barragán B; Cruz-Osorio RM; Gutiérrez-Zepeda BM; Quintero-Ramos A; Becerra-Loaiza DS
    Front Immunol; 2023; 14():1194262. PubMed ID: 37795094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal peripheral blood neutrophil numbers accompanying
    Horwitz MS; Laurino MY; Keel SB
    Blood Adv; 2019 Aug; 3(16):2470-2473. PubMed ID: 31427279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICON: the early diagnosis of congenital immunodeficiencies.
    Routes J; Abinun M; Al-Herz W; Bustamante J; Condino-Neto A; De La Morena MT; Etzioni A; Gambineri E; Haddad E; Kobrynski L; Le Deist F; Nonoyama S; Oliveira JB; Perez E; Picard C; Rezaei N; Sleasman J; Sullivan KE; Torgerson T
    J Clin Immunol; 2014 May; 34(4):398-424. PubMed ID: 24619621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.
    Horwitz MS; Corey SJ; Grimes HL; Tidwell T
    Hematol Oncol Clin North Am; 2013 Feb; 27(1):19-41, vii. PubMed ID: 23351986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of primary immunodeficiency diseases in iran.
    Aghamohammadi A; Moin M; Rezaei N
    Iran J Pediatr; 2010 Mar; 20(1):16-34. PubMed ID: 23056678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.
    van de Vosse E; Verhard EM; Tool AJ; de Visser AW; Kuijpers TW; Hiemstra PS; van Dissel JT
    Ann Hematol; 2011 Feb; 90(2):151-8. PubMed ID: 20803142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.
    Xia J; Bolyard AA; Rodger E; Stein S; Aprikyan AA; Dale DC; Link DC
    Br J Haematol; 2009 Nov; 147(4):535-42. PubMed ID: 19775295
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.